ACE inhibitors for heart failure: a question of dose.
作者信息
Cleland J G, Poole-Wilson P A
机构信息
Royal Postgraduate Medical School, Hammersmith Hospital, London.
出版信息
Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106.
Abstract
摘要
相似文献
1
ACE inhibitors for heart failure: a question of dose.用于治疗心力衰竭的血管紧张素转换酶抑制剂：剂量问题。
Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106.
2
ACE inhibitors in heart failure. What dose?心力衰竭中的血管紧张素转换酶抑制剂。用多大剂量？
Postgrad Med J. 1995 Feb;71(832):65-6. doi: 10.1136/pgmj.71.832.65.
3
Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?心力衰竭患者开始使用血管紧张素转换酶抑制剂治疗：如何用药、在何处用药以及用药剂量是多少？
Br Heart J. 1993 Apr;69(4):282-3. doi: 10.1136/hrt.69.4.282.
4
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
Cardiol Clin. 2008 Feb;26(1):1-14, v. doi: 10.1016/j.ccl.2007.12.001.
5
[When must, when should, when can ACE inhibitors be administered in heart failure?].[在心力衰竭中，血管紧张素转换酶抑制剂必须在何时、应该在何时以及能够在何时使用？]
Med Klin (Munich). 1993 Aug 15;88(8):496-502.
6
[Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].[血管紧张素转换酶抑制剂在动脉高血压和心力衰竭中的应用。剂量问题]
Med Clin (Barc). 2000;114 Suppl 2:24-7.
7
Intermittent non-adherence with ACE inhibitor treatment and its implications for clinical trials results.ACE抑制剂治疗的间歇性不依从性及其对临床试验结果的影响。
Heart. 2001 Feb;85(2):213-4. doi: 10.1136/heart.85.2.213.
8
[Management of the treatment with converting enzyme inhibitors in chronic heart failure].[慢性心力衰竭中转换酶抑制剂治疗的管理]
Rev Prat. 1992 Dec 15;42(20):2563-7.
9
Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
Circulation. 2005 Oct 18;112(16):2380-2. doi: 10.1161/CIRCULATIONAHA.105.586545.
10
[ACE inhibitors in heart failure: the highest dose always and in every case?].[心力衰竭中的血管紧张素转换酶抑制剂：总是且在每种情况下都用最高剂量吗？]
G Ital Cardiol. 1999 Jul;29(7):816-23.
引用本文的文献
1
Clinical case studies in heart failure management.心力衰竭管理中的临床病例研究
Br J Clin Pharmacol. 1999 Mar;47(3):239-47. doi: 10.1046/j.1365-2125.1999.00882.x.
2
Optimal treatment of heart failure in the elderly.老年人心力衰竭的最佳治疗方法。
Drugs Aging. 1997 Jun;10(6):435-43. doi: 10.2165/00002512-199710060-00004.
3
The renin-angiotensin system and cardiac remodelling after acute myocardial infarction.急性心肌梗死后的肾素-血管紧张素系统与心脏重塑
Heart. 1996 Nov;76(3 Suppl 3):68-72. doi: 10.1136/hrt.76.3_suppl_3.68.
4
Is aspirin safe for patients with heart failure?阿司匹林对心力衰竭患者是否安全？
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
本文引用的文献
1
Early treatment with captopril after acute myocardial infarction.急性心肌梗死后早期使用卡托普利治疗。
Br Heart J. 1993 Mar;69(3):215-22. doi: 10.1136/hrt.69.3.215.
2
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
Eur Heart J. 1993 Feb;14(2):273-8. doi: 10.1093/eurheartj/14.2.273.
3
Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.急性心肌梗死后早期使用依那普利治疗的神经激素效应及其对左心室重构的影响。
Eur Heart J. 1993 Aug;14(8):1110-7. doi: 10.1093/eurheartj/14.8.1110.
4
Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.赖诺普利对无症状左心室功能不全患者心肺、神经内分泌及肾功能的影响。
Br Heart J. 1993 Jun;69(6):512-5. doi: 10.1136/hrt.69.6.512.
5
Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial.
Eur Heart J. 1993 Jul;14 Suppl C:18-23. doi: 10.1093/eurheartj/14.suppl_c.18.
6
Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
Eur Heart J. 1994 Feb;15(2):247-54. doi: 10.1093/oxfordjournals.eurheartj.a060484.
7
Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.血管紧张素转换酶抑制期间影响血管紧张素代谢的多种因素：来自分子生物学和遗传学研究的见解
Br Heart J. 1994 Sep;72(3 Suppl):S3-10. doi: 10.1136/hrt.72.3_suppl.s3.
8
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.卡托普利治疗：肾素、血管紧张素I和II、醛固酮及血压的剂间变化
Br J Clin Pharmacol. 1982 Jun;13(6):855-8. doi: 10.1111/j.1365-2125.1982.tb01878.x.
9
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.卡托普利治疗临床高血压。肾素 - 血管紧张素系统各组分及身体成分的变化与血压下降的关系，并附关于转换酶抑制期间血管紧张素II测量的说明
Br Heart J. 1980 Sep;44(3):290-6. doi: 10.1136/hrt.44.3.290.
10
Captopril in heart failure. A double blind controlled trial.卡托普利治疗心力衰竭。一项双盲对照试验。
Br Heart J. 1984 Nov;52(5):530-5. doi: 10.1136/hrt.52.5.530.
Zotero 插件